Suppr超能文献

后房型虹膜夹型人工晶状体植入联合穿透性角膜移植术后的视力结果和并发症。

Visual outcomes and complications following posterior iris-claw aphakic intraocular lens implantation combined with penetrating keratoplasty.

机构信息

Department of Ophthalmology, Charité, University Medicine Berlin, Augustenburger Platz 1, 13353, Berlin, Germany,

出版信息

Graefes Arch Clin Exp Ophthalmol. 2013 Apr;251(4):1151-6. doi: 10.1007/s00417-012-2226-y. Epub 2012 Dec 19.

Abstract

BACKGROUND

To evaluate the indication, visual outcome, and complication rate after implantation of a posterior iris-claw aphakic intraocular lens (IOL) during penetrating keratoplasty.

METHODS

This retrospective study comprised 23 eyes (23 patients) without adequate capsule support undergoing posterior iris-claw aphakic IOL implantation (Verisyse/Artisan) during penetrating keratoplasty between 2005 and 2010. Mean follow-up was 18 months (range from 12 to 37 months).

RESULTS

The IOLs were inserted during an IOL exchange in 17 eyes and as a secondary procedure in six aphakic eyes. Pseudophakic bullous keratopathy with corneal scar after anterior chamber intraocular lens (ACIOL) was the main indication for penetrating keratoplasty in 16 eyes (69.6 %). The final corrected distance visual acuity (CDVA) in logMAR (mean 1.0 ± 0.46) improved significantly (p < 0.05) compared to the preoperative CDVA (mean 1.8 ± 0.73). Twenty eyes (86.9 %) had a final visual acuity in logMAR better than the pre-operative CDVA. The mean postoperative IOP 16.3 mmHg ± 4.0 was not significantly (p > 0.05) higher compared to the preoperative IOP 15.6 mmHg ± 5.1. Complications included slight temporary pupil ovalization in three eyes (13.0 %) and iris-claw IOL sublocation in three eyes (13.0 %); all IOLs could be easily repositioned. Cystoid macular edema occured in one eye (4.3 %) 8 weeks after primary surgery. All grafts remained clear without any sign of graft rejection.

CONCLUSIONS

Retropupillar iris-claw IOL during penetrating keratoplasty provides good visual outcomes with a favorable complication rate, and can be used for a wide range of indications in eyes without adequate capsule support.

摘要

背景

评估穿透性角膜移植术中后房型虹膜夹型无晶状体眼人工晶状体(IOL)植入的适应证、视力结果和并发症发生率。

方法

本回顾性研究包括 2005 年至 2010 年间 23 只眼(23 例患者)因缺乏囊袋支持而接受后房型虹膜夹型无晶状体眼 IOL(Verisyse/Artisan)植入的患者。平均随访时间为 18 个月(12 至 37 个月)。

结果

17 只眼行 IOL 置换时植入 IOL,6 只眼无晶状体眼行二期手术植入。16 只眼(69.6%)穿透性角膜移植术的主要适应证是前房人工晶状体(ACIOL)后发性白内障伴角膜瘢痕。最终 logMAR 最佳矫正视力(BCVA)(均值 1.0 ± 0.46)较术前 logMAR 最佳矫正视力(均值 1.8 ± 0.73)显著提高(p<0.05)。20 只眼(86.9%)的最终视力优于术前 logMAR 最佳矫正视力。术后平均眼压 16.3mmHg ± 4.0,与术前眼压 15.6mmHg ± 5.1 相比差异无统计学意义(p>0.05)。3 只眼(13.0%)出现轻微短暂性瞳孔椭圆形,3 只眼(13.0%)出现虹膜夹 IOL 下移位,所有 IOL 均能轻松复位。1 只眼(4.3%)在初次手术后 8 周发生黄斑囊样水肿。所有移植物均保持透明,无移植物排斥迹象。

结论

穿透性角膜移植术中后房型虹膜夹型 IOL 提供了良好的视力结果,并发症发生率低,可用于无囊袋支持的多种适应证的眼。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验